DAVID OST to Adenocarcinoma
This is a "connection" page, showing publications DAVID OST has written about Adenocarcinoma.
Connection Strength
0.908
-
Development and Revision of Meaningful Stage Descriptors for M1a Non-Small Cell Lung Cancer. Chest. 2024 Mar; 165(3):490-491.
Score: 0.251
-
A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER. Am J Respir Crit Care Med. 2020 01 15; 201(2):212-223.
Score: 0.189
-
Interventional Bronchoscopy in 2015. Removing Endoluminal and Methodological Obstructions. Ann Am Thorac Soc. 2015 Sep; 12(9):1265-6.
Score: 0.139
-
How and when to use genetic markers for nonsmall cell lung cancer. Curr Opin Pulm Med. 2013 Jul; 19(4):331-9.
Score: 0.120
-
A randomized trial of CT fluoroscopic-guided bronchoscopy vs conventional bronchoscopy in patients with suspected lung cancer. Chest. 2008 Sep; 134(3):507-513.
Score: 0.085
-
Survival after surgery in stage IA and IB non-small cell lung cancer. Am J Respir Crit Care Med. 2008 Mar 01; 177(5):516-23.
Score: 0.081
-
Non-small cell lung cancer transdifferentiation into small cell lung cancer: A case series. Lung Cancer. 2018 08; 122:220-223.
Score: 0.042